Northwest Biotherapeutics NWBO
OTC NWBO
$0.15 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Northwest Biotherapeutics (NWBO) Operating Expenses (2010 - 2026)

Updated

Northwest Biotherapeutics' Operating Expenses was $12.41 million in Q2 2026, down 16.8% from $14.91 million a year earlier but up 8.9% from the prior quarter.

Analysis

Northwest Biotherapeutics (NWBO) Operating Expenses (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Northwest Biotherapeutics' Operating Expenses was $52.5 million through Jun 30, 2026, down 21.0% year-over-year; for FY2025, it was $61.29 million, down 9.7% from FY2024.

  • Operating Expenses shows a five-year compound annual growth rate of -7.0% (FY2020 to FY2025).
  • In earlier years, Operating Expenses was $67.89 million in FY2024 (+18.2%), $57.44 million in FY2023 (-16.6%), $68.86 million in FY2022 (+28.2%) and $53.71 million in FY2021 (-38.9%).
  • Quarterly Operating Expenses has moved between $10.4 million (Q3 2021) and $21.58 million (Q2 2022) over five years.
  • Compared with a year earlier, Operating Expenses has declined for five straight quarters, with an average decline of 7.6% over the last eight quarters.
  • The best year-over-year quarter for Operating Expenses over five years was Q4 2022 (growth of 75.9%); the worst was Q3 2021 (a decline of 78.4%).
  • Per Business Quant data, NWBO's Operating Expenses in the three quarters before Q2 2026 was $11.39 million (Q1 2026), $14.18 million (Q4 2025) and $14.52 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 10.12 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 10.56 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -9.70 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 2.09 Bn
10 Northwest Biotherapeutics 250.40 Mn 240.41 Mn - 12.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.41 Mn
Mar 31, 2026 11.39 Mn
Dec 31, 2025 14.18 Mn
Sep 30, 2025 14.52 Mn
Jun 30, 2025 14.91 Mn
Mar 31, 2025 17.69 Mn
Dec 31, 2024 18.73 Mn
Sep 30, 2024 15.16 Mn
Jun 30, 2024 17.97 Mn
Mar 31, 2024 16.03 Mn
Dec 31, 2023 15.59 Mn
Sep 30, 2023 14.23 Mn
Jun 30, 2023 13.78 Mn
Mar 31, 2023 13.84 Mn
Dec 31, 2022 18.78 Mn
Sep 30, 2022 15.82 Mn
Jun 30, 2022 21.58 Mn
Mar 31, 2022 12.69 Mn
Dec 31, 2021 10.68 Mn
Sep 30, 2021 10.40 Mn
API Access

Northwest Biotherapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=NWBO&period=max&api_key=YOUR_API_KEY